chevron-down Created with Sketch Beta.

The Health Lawyer - June 2020

Vol. 32 No. 5  

Featured Articles


The Path to Successful Utilization of Alternative Payment Models

The U.S. healthcare system is in the process of shifting from traditional fee-for-service (FFS) payment to value-based alternative payment models (APMs). The number of APMs were significantly accelerated by the Patient Protection and Affordable Care Act (PPACA), which established the Medicare Shared Savings Program (MSSP) for accountable care organizations (ACOs).


COVID-19 and Resource Allocation: Planning for Times of Scarce Medical Resources

President Theodore Roosevelt once reportedly said, “In any moment of decision, the best thing you can do is the right thing, the next best thing is the wrong thing, and the worst thing you can do is nothing.” During the COVID-19 pandemic, it has not always been easy to determine what doing the right thing means. In times when medical resources become scarce, choices may have to be made as to who should receive limited medical supplies and services.


COVID-19 and the Pharmaceutical Industry in Singapore and Myanmar: A Comparison of Developed and Frontier Markets

The COVID-19 Coronavirus pandemic continues to wreak havoc and sow disruption around the world. In response, health authorities, pharmaceutical companies, life science laboratories and research centers (the “Pharmaceutical Industry”) are scrambling to develop potential treatments, viable inoculations, test kits and related products (the “Products”).